The MYH9/APOL1 region and chronic kidney disease in European-Americans

Human Molecular Genetics

Volumn 20, Issue 12, 2011, Pages 2450-2456

  O'Seaghdha, Conall M ^a,b   Parekh, Rulan S ^c,d   Hwang, Shih Jen ^a   Li, Man ^d   ttgen, Anna Kö ^d,g   Coresh, Josef ^d,e   Yang, Qiong ^f   Fox, Caroline S ^a,b   Linda Kao, W H ^d,e,h  

^a FRAMINGHAM HEART STUDY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BOSTON UNIVERSITY   (United States)

^g UNIVERSITY OF FREIBURG   (Germany)

^h NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APOL1 GENE; ARTICLE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; EUROPEAN AMERICAN; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYH9 GENE; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; KIDNEY DISEASES; MODELS, BIOLOGICAL; MOLECULAR MOTOR PROTEINS; MYOSIN HEAVY CHAINS; POLYMORPHISM, SINGLE NUCLEOTIDE; UNITED STATES;

EID: 79957491313     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr118     Document Type: Article

References (35)

1. Coresh, J., Selvin, E., Stevens, L.A., Manzi, J., Kusek, J.W., Eggers, P., Van Lente, F. and Levey, A.S. (2007) Prevalence of chronic kidney disease in the United States. JAMA, 298, 2038-2047.
2. Chow, K.M., Wong, T.Y. and Li, P.K. (2005) Genetics of common progressive renal disease. Kidney Int. Suppl., 94, S41-S45.
3. Kottgen, A., Glazer, N.L., Dehghan, A., Hwang, S.J., Katz, R., Li, M., Yang, Q., Gudnason, V., Launer, L.J., Harris, T.B. et al. (2009) Multiple loci associated with indices of renal function and chronic kidney disease. Nat. Genet., 17, 428-437.
4. Kopp, J.B., Smith, M.W., Nelson, G.W., Johnson, R.C., Freedman, B.I., Bowden, D.W., Oleksyk, T., McKenzie, L.M., Kajiyama, H., Ahuja, T.S. et al. (2008) MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat. Genet., 40, 1175-1184.
5. Kao, W.H., Klag, M.J., Meoni, L.A., Reich, D., Berthier-Schaad, Y., Li, M., Coresh, J., Patterson, N., Tandon, A., Powe, N.R. et al. (2008) MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat. Genet., 40, 1185-1192.
6. Freedman, B.I., Hicks, P.J., Bostrom, M.A., Comeau, M.E., Divers, J., Bleyer, A.J., Kopp, J.B., Winkler, C.A., Nelson, G.W., Langefeld, C.D. et al. (2009) Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol. Dial. Transplant., 24, 3366-3371.
7. Genovese, G., Friedman, D.J., Ross, M.D., Lecordier, L., Uzureau, P., Freedman, B.I., Bowden, D.W., Langefeld, C.D., Oleksyk, T.K., Uscinski Knob, A.L. et al. (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science, 329, 841-845.
8. Price, A.L., Patterson, N., Yu, F., Cox, D.R., Waliszewska, A., McDonald, G.J., Tandon, A., Schirmer, C., Neubauer, J., Bedoya, G. et al. (2007) A genomewide admixture map for Latino populations. Am. J. Hum. Genet., 80, 1024-1036.
9. Behar, D.M., Rosset, S., Tzur, S., Selig, S., Yudkovsky, G., Bercovici, S., Kopp, J.B., Winkler, C.A., Nelson, G.W., Wasser, W.G. et al. (2010) African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans. Hum. Mol. Genet., 19, 1816-1827.
10. Bedoya, G., Montoya, P., Garcia, J., Soto, I., Bourgeois, S., Carvajal, L., Labuda, D., Alvarez, V., Ospina, J., Hedrick, P.W. et al. (2006) Admixture dynamics in Hispanics: a shift in the nuclear genetic ancestry of a South American population isolate. Proc. Natl Acad. Sci. USA, 103, 7234-7239.
11. Matsushita, T., Hayashi, H., Kunishima, S., Hayashi, M., Ikejiri, M., Takeshita, K., Yuzawa, Y., Adachi, T., Hirashima, K., Sone, M. et al. (2004) Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice. Biochem. Biophys. Res. Commun., 325, 1163-1171.
12. Arrondel, C., Vodovar, N., Knebelmann, B., Grunfeld, J.P., Gubler, M.C., Antignac, C. and Heidet, L. (2002) Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J. Am. Soc. Nephrol., 13, 65-74.
13. Faul, C., Asanuma, K., Yanagida-Asanuma, E., Kim, K. and Mundel, P. (2007) Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol., 17, 428-437.
14. Nelson, G.W., Freedman, B.I., Bowden, D.W., Langefeld, C.D., An, P., Hicks, P.J., Bostrom, M.A., Johnson, R.C., Kopp, J.B. and Winkler, C.A. (2010) Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15. Hum. Mol. Genet., 19, 1805-1815.
15. Tzur, S., Rosset, S., Shemer, R., Yudkovsky, G., Selig, S., Tarekegn, A., Bekele, E., Bradman, N., Wasser, W.G., Behar, D.M. et al. (2010) Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum. Genet., 128, 345-350.
16. Freedman, B.I., Kopp, J.B., Langefeld, C.D., Genovese, G., Friedman, D.J., Nelson, G.W., Winkler, C.A., Bowden, D.W. and Pollak, M.R. (2010) The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J. Am. Soc. Nephrol., 21, 1422-1426.
17. Barreiro, L.B., Laval, G., Quach, H., Patin, E. and Quintana-Murci, L. (2008) Natural selection has driven population differentiation in modern humans. Nat. Genet., 40, 340-345.
18. Sabeti, P.C., Varilly, P., Fry, B., Lohmueller, J., Hostetter, E., Cotsapas, C., Xie, X., Byrne, E.H., McCarroll, S.A., Gaudet, R. et al. (2007) Genome-wide detection and characterization of positive selection in human populations. Nature, 449, 913-918.
19. Oleksyk, T.K., Nelson, G.W., An, P., Kopp, J.B. and Winkler, C.A. (2010) Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa. PLoS One, 5, e11474.
20. Sabeti, P.C., Schaffner, S.F., Fry, B., Lohmueller, J., Varilly, P., Shamovsky, O., Palma, A., Mikkelsen, T.S., Altshuler, D. and Lander, E.S. (2006) Positive natural selection in the human lineage. Science, 312, 1614-1620.
21. Franceschini, N., Voruganti, V.S., Haack, K., Almasy, L., Laston, S., Goring, H.H., Umans, J.G., Lee, E.T., Best, L.G., Fabsitz, R.R. et al. (2010) The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study. Hum. Genet., 127, 295-301.
22. Freedman, B.I., Hicks, P.J., Bostrom, M.A., Cunningham, M.E., Liu, Y., Divers, J., Kopp, J.B., Winkler, C.A., Nelson, G.W., Langefeld, C.D. et al. (2009) Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int., 75, 736-745.
23. Tian, C., Gregersen, P.K. and Seldin, M.F. (2008) Accounting for ancestry: population substructure and genome-wide association studies. Hum. Mol. Genet., 17, R143-150.
24. Price, A.L., Butler, J., Patterson, N., Capelli, C., Pascali, V.L., Scarnicci, F., Ruiz-Linares, A., Groop, L., Saetta, A.A., Korkolopoulou, P. et al. (2008) Discerning the ancestry of European Americans in genetic association studies. PLoS Genet., 4, e236.
25. Lundmark, P.E., Liljedahl, U., Boomsma, D.I., Mannila, H., Martin, N.G., Palotie, A., Peltonen, L., Perola, M., Spector, T.D. and Syvanen, A.C. (2008) Evaluation of HapMap data in six populations of European descent. Eur. J. Hum. Genet., 16, 1142-1150.
26. Dawber, T.R., Kannel, W.B. and Lyell, L.P. (1963) An approach to longitudinal studies in a community: the Framingham Study. Ann. N. Y. Acad Sci, 107, 539-556.
27. Kannel, W.B., Feinleib, M., McNamara, P.M., Garrison, R.J. and Castelli, W.P. (1979) An investigation of coronary heart disease in families. The Framingham offspring study. Am. J. Epidemiol., 110, 281-290.
28. Feinleib, M., Kannel, W.B., Garrison, R.J., McNamara, P.M. and Castelli, W.P. (1975) The Framingham Offspring Study. Design and preliminary data. Prev. Med., 4, 518-525.
29. Govindaraju, D.R., Cupples, L.A., Kannel, W.B., O'Donnell, C.J., Atwood, L.D., D'Agostino, R.B. Sr, Fox, C.S., Larson, M., Levy, D., Murabito, J. et al. (2008) Genetics of the Framingham Heart Study population. Adv. Genet., 62, 33-65.
30. (1989) The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am. J. Epidemiol., 129, 687-702.
31. Levey, A.S., Bosch, J.P., Lewis, J.B., Greene, T., Rogers, N. and Roth, D. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med., 130, 461-470.
32. Fox, C.S., Larson, M.G., Leip, E.P., Culleton, B., Wilson, P.W. and Levy, D. (2004) Predictors of new-onset kidney disease in a community-based population. JAMA, 291, 844-850.
33. Hsu, C.C., Kao, W.H., Coresh, J., Pankow, J.S., Marsh-Manzi, J., Boerwinkle, E. and Bray, M.S. (2005) Apolipoprotein E and progression of chronic kidney disease. JAMA, 293, 2892-2899.
34. Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A. and Reich, D. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet., 38, 904-909.
35. Dadd, T., Weale, M.E. and Lewis, C.M. (2009) A critical evaluation of genomic control methods for genetic association studies. Genet. Epidemiol., 33, 290-298.